baber/WOPTO huggingface dataset:
Patent IE-33445-L (IE)
Title: Pentol derivatives
IPC: C07C67/00
Filed: 1969-07-02
Abstract: 1,248,529. Arabitol derivatives. CIBAGEIGY A.G. 30 June, 1969 [5 July, 1968], No. 32921/69. Heading C2C. Novel compounds I in which each of R 2 , R 4 and R 5 is an optionally substituted hydrocarbon radical and their O- acyl derivatives are prepared by reduction of novel compounds II or their acyl derivatives, or by splitting off the group X in a compound III wherein X is an optionally substituted methylene group, followed where desired by acylation. Compounds II are prepared by treatment of compounds IV with a glycol splitting oxidizing agent. Intermediates isolated which are prepared by the usual methods are compounds III and IV, 1,2 - O - -isopropylidene - 3 - O - n -propyl - α - D- glucofuranose; 1,2 - O - isopropylidene - 3 - O- n - propyl - 5,6 - di - O - (4 - chlorobenzyl) - a- D-glucofuranose and the corresponding 3-O- methyl derivative; ethyl-3-O-methyl-5,6-di-O, (4 - chlorobenzyl) - D - glucofuranoside; 1,2- O - isopropylidene - 6 - O - phenyl - α - D - glucofuranose; 1,2 - O - isopropylidene - 3,5 - di - O- acetyl - 6 - O - phenyl - α- D - glucofuranose; 1,2 - O - isopropylidene - 3,5 - di - O - benzyl - 6- O - phenyl - α - D - glucofuranose; ethyl - 3,5- di - O - benzyl - 6 - O - phenyl - D - glucofuranoside; 1,2 - O - isopropylidene - 6 - O - (4- chlorophenyl)-α-D-glucofuranose and its 3,5-di- O - acetyl and 3,5 - di - O - benzyl derivatives; ethyl - 3,4 - di - O - benzyl - 6 - (4 - chlorophenyl) - D - glucofuranoside; 1,2 - O - isopropylidene - 6 - O - (4 - methoxyphenyl) - α - D- glucofuranose and its 3,5-di-O-acetyl and 3,5-di- O-benzyl derivatives; ethyl-3,5-di-O-benzyl-6- O - (4 - methoxyphenyl) - D - glucofuranoside; 1,2 - isopropylidene - 3 - O - allyl - 5,6 - di - O - benzyl - α - D - glucofuranose; ethyl 3 - O - allyl - 5,6 - di - O - benzyl - D - glucofuranoside; 1,2 - O - isopropylidene - 3 - O - benzyl - 5,6 - di- O - benzoyl - α - D - glucofuranose; and ethyl- 3 - O - benzyl - 5,6 - di - O - benzoyl - D - glucofuranoside. Pharmaceutical compositions comprise compounds I or II in conjunction with suitable carriers, are administered orally or parenterally and are useful as anti-inflammatory agents.
[GB1248529A]
Patent FI-821012-L (FI)
Inventor: PETERSON LARS GUSTAF BIRGER
IPC: A43B13/20
Filed: 1982-03-23
Abstract: A shoe sole construction designed so as to be biodynamically shock-absorbing.In the sole (2) are provided two cushions (8, 9) which are filled with a fluid (10) and interconnected by means of a number of channels (11). One cushion (8) is positioned underneath the heel (6) of the foot and the other cushion (9) is positioned underneath the transverse forward arch (7) of the foot.When the wearer of the shoe sets down his foot into contact with the ground, the heel strikes the ground first and a shock-absorbing effect is then obtained as the rear cushion is compressed. Upon this compression, fluid flows from the rear cushion (8) to the front cushion (9), which expands and lifts the front arch of the foot, releaving the weight thereon and supporting the front arch when the forefoot is set down on the ground. When the wearer continues the walking cycle, the forward cushion (9) is compressed, causing the rear cushion (8) to expand and the latter is again ready to provide a shock-absorbing effect upon the next step and heel strike.
Patent FI-830682-L (FI)
Inventor: DOERRIES PETER
IPC: D06N7/00
Filed: 1983-03-01
Abstract: A carrier web coated with amino resin wherein at least one surface is resinated is produced by applying a spreadable amino resin dispersion containing 70-90% by weight of amino resin and 30-10% by weight of a liquid dispersant to at least one surface of an uncoated carrier web in an apparatus comprising: (a) unwinding station for unwinding uncoated carrier webs from rotatable supply rolls, (b) means for conveying the uncoated webs comprising a plurality of cooperating pressure rolls rotatably mounted in parallel relationship, (c) a coating means for applying a brushable amino resin dispersion to the web, and (d) a belt press for compression-molding and curing the coated web.
Patent IE-891153-L (IE)
Title: Wrap-around carton locking means
IPC: B65D71/00
Filed: 1989-04-11
Abstract: A carbon having a bottom panel comprised of two overlapping flaps. The outer flap has a primary male tab engaging a primary female locking edge in the inner flap, while the inner flap has a secondary male locking tab engaging a secondary female locking opening in the outer flap. The secondary locking tab is connected to the carbon along a fold line coinciding with the fold line connecting the inner flap to the adjacent side panel, allowing a large secondary locking tab to be used even though the bottom panel is narrow. The outer and inner flaps are able to overlap across substantially the full width of the flaps to form a bottom panel of double thickness.
[US4860943A]
Patent IE-42875-L (IE)
Title: Dispensing pump
IPC: F04B9/14
Filed: 1976-06-25
Abstract: A dispensing pump for application to a product container includes an elongated housing having a recess in a sidewall thereof and a flexible bulbous diaphragm seated over the recess for a trigger-type actuation as the housing is gripped in the manner of a handle. A variable volume pump chamber is defined by the diaphragm together with the recess, and an inlet passage is provided in the housing through which the product passes from the container into the recess. The diaphragm has an annular inner skirt for closing the inlet passage in response to axial deformation of the diaphragm, as well as intermediate and outer annular skirts. The intermediate skirt has a lower free edge portion normally covering a discharge port in the housing which communicates with the pump housing, and the outer skirt has a lower free edge portion normally covering a vent port in the housing which communicates with the atmosphere. The lower edge portions of the intermediate and outer skirts are of resilient flexible materials so as to respectively uncover the discharge and vent ports in response to a given fluid pressure therewithin. Accordingly, the inlet passage is closed upon depression of the diaphragm and the discharge passage is simultaneously uncovered to permit the contents of the diaphragm to be discharged. Upon release of the diaphragm the vacuum pressure thereby created effects a closing of the discharge passage and an opening of the inlet passage for refilling of the pump chamber. As the dispensable product is withdrawn from the container, the vacuum pressure therein created effects an opening of the vent passage and permits air to flow into the container.[US3987938A]
Patent IE-901398-L (IE)
Title: Process for the production of cholesterol-reduced butterfat¹or butter, butter(fat), and plant for the production thereof
IPC: A23C15/14
Filed: 1990-04-19
Abstract: In a process for producing low-cholesterol butter fat or butter by steam treatment, the fat is treated with steam in one or more horizontal or slightly inclined reaction pipes at a temperature of 195 to 250 DEG C and a pressure of 0.5 to 5 mbar. The steam is injected through steam-outlet holes in the walls of mutually parallel steam pipes which extend through the layer that conducts the liquid fat (oil) along the whole length of the reaction pipe parallel to the axis of the pipe. The vapour is removed and the fat, to which fat recombination substances may be added, is cooled. The low-cholesterol butter fat of butter can be readily obtained in an installation which contains several reaction pipes, and can be advantageously used to manufacture foods and luxury foodstuffs, in particular for dietetic products, or consumed or processed directly as a dietary fat.
Patent IE-37127-L (IE)
Title: Purification of kallikrein.
IPC: A61K38/48
Filed: 1972-11-02
Abstract: 1384335 Medicines comprising kallikreins BAYER AG 2 Now 1972 [3 Nov 1971 (2)] 50559/72 Heading A5B [Also in Division C3] A pharmaceutical composition comprises Kallikrein or Kallikrein component A and/or Kallikrein component B which has been obtained by (1) adsorbing the Kallikrein from an impure solution onto a macroporous anion exchanger and eluting it therefrom to obtain an eluted solution containing Kallikrein; and (2) contacting the eluted solution with a macroporous cation exchanger and separating the exchanger therefrom to produce a pure solu- tion of Kallikrein. The enzyme may be in crystalline form (see Division C3).
[GB1384335A]
Patent IE-851537-L (IE)
Title: Amino fatty peroxyacid salts of bleaches
IPC: F16B15/00
Filed: 1985-06-20
Abstract: Per-acids and per-acid precursor compounds of the general type RXAOOH and RXAL, wherein R is a hydrocarbyl group, X is a hetero-atom, A is a carbonyl bridging group and L is a leaving group, especially oxybenzenesulfonate, are useful bleaching compounds for fabrics. Laundry products containing same are disclosed.
Patent IE-871559-L (IE)
Title: Controlled release combination of carbidopa/levodopa.
IPC: A61K9/22
Filed: 1987-06-12
Abstract: A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levodopa combinations presently employed.
Patent IE-35904-L (IE)
Title: 1, 3-disubstituted benzenes
IPC: C07C45/29
Filed: 1971-12-17
Abstract: 1317090 Tetrahydroindane ketones F HOFFMAXN-LA ROCHE & CO AG 20 Dec 1971 [21 Dec 1970] 59018/71 Headings C2C and C2U The invention comprises compounds having the general formula wherein R<SP>1</SP> is a primary alkyl group having 1 to 5 carbon atoms, R<SP>2</SP> and R<SP>4</SP> each represent a hydrogen atom or together represent a carboncarbon bond, R<SP>3</SP> is a primary alkyl group having 1 to 8 carbon atoms or a cycloalkyl group having 3 to 8 carbon atoms, R<SP>5</SP> is a hydrogen atom or, when R<SP>2</SP> and R<SP>4</SP> together are a carbon-carbon bond, R<SP>6</SP> and R<SP>9</SP> together form a carbon-carbon bond, R<SP>9</SP> is the group OR<SP>6</SP> or, when R<SP>2</SP> and R<SP>4</SP> are a carbon-carbon bond, R<SP>5</SP> and R<SP>9</SP> together are a carbon-carbon bond, R<SP>6</SP> is hydrogen or an acyl or aroyl group, Z is a >C=O group or a group, R<SP>7</SP> is hydrogen or an acyl, alkyl, aralkyl or tetrahydropyran-2-yl group, R<SP>8</SP> is hydrogen or an aliphatic hydrocarbyl group and m is 1 or 2. They may be prepared by reacting a compound having the formula where R<SP>12</SP> is a chlorine, bromine or iodine atom or a hydroxy, alkoxy, hydrocarbylamino or dihydrocarbylamino group with a compound of the general formula and, if desired, converting the carbonyl group adjacent to R<SP>1</SP> in the reaction product of the formula into a group of the formula and/or, if desired, esterifying the hydroxy group of the compound to form a compound of the general formula where R<SP>6 1</SP> is an acyl or aroyl group, and/or, if desired, treating a compound of the general formula with strong acid to give a compound of the general formula and, if desired, catalytically hydrogenating the compound (1a<SP>1</SP>) with one mole equivalent of hydrogen to give a compound of the formula The compound (Ib) may be catalytically hydrogenated to give The compound (Ia<SP>1</SP>) may be further catalytically hydrogenated with two mole equivalents of hydrogen to give The compound (Ib) may be further catalytically hydrogenated with two mole equivalents of hydrogen to give (XI). The compound (Ic<SP>1</SP>) may be reacted with a strong acid to give a steroid having the general formula such as dl-equilenin methyl ether. Also, in one example racemic 4-[2-(3-methoxyphenyl) - ethyl] - 7α# - methyl - perhydroindane- 1,5-dione is cyclized to give a mixture of racemic 9(11)-dehydroestrone methyl ether and racemic 14#-8(9) - dehydroestrone methyl ether. In another example d-(+)-3-methoxy-estra- 1,3,5(10),9(11) - tetraen - 17 - one is prepared similarly from optically active starting material.
[GB1317090A]
Patent IE-40515-L (IE)
Title: 7-(ó- amino-arylacetamido)-cephalosporins
IPC: C07D501/20
Filed: 1974-09-04
Abstract: 1436409 Peptide derivatives of cephalosporins PFIZER Ltd 5 Dec 1974 [13 Sept 1973] 43033/73 Heading C3H [Also in Division C2] Novel cephalosporins I (in which R<SP>1</SP> is phenyl, 2- or 3-thienyl, or 2- furyl, the phenyl and thienyl groups optionally being substituted by one or more of halo, OH, CF 3 or 1-6 C alkyl or alkoxy; R is OH and R<SP>2</SP> is H, OH, OCOCH 3 , OCONH 2 , N-pyridyl, substituted N-pyridyl, azido or heterocyclylthio or R and R<SP>2</SP> together represent an -O- atom ; R<SP>3</SP> is COOH, SO 3 H, COOR<SP>4</SP> or CONR<SP>5</SP>R<SP>6</SP>; R<SP>4</SP> is 1-6 C alkyl, 5-indanyl, naphthyl or phenyl optionally substituted by halo, CF 3 or 1-6C alkyl or alkoxy; R<SP>5</SP> and R<SP>6</SP> are H, 1-6C alkyl or cycloalkyl or NR<SP>5</SP>R<SP>6</SP> is a saturated heterocyclyl group; X is -NR<SP>7</SP>-, R<SP>7</SP> is H, 1-6 C alkyl, 2-6 C alkenyl, or benzyl; alk<SP>1</SP> is -OH 2 - and alk<SP>2</SP> is a 1-3C divalent, saturated aliphatic hydrocarbon radical) and salts thereof are prepared by (1) reacting a compound II with a cyclic anhydride III or IV (in which X is other than -NH-); (2) reacting a compound II with a compound VI or a compound IX (in which X is other than -NH-) or with an acid chloride, activated ester or mixed anhydride of a compound VI or IX; (3) deprotecting a compound I in which X is -NR<SP>7'</SP>-, R<SP>7'</SP> being a protecting group, to give a compound I in which X is NH; (4) reacting a compound I in which R<SP>2</SP> is OCOCH 3 with an appropriate pyridine, sodium azide or heterocyclic thiol to give a compound I in which R<SP>2</SP> is N-pyridyl, azido or heterocyclylthio; (5) reacting a compound I in which R and R<SP>2</SP> are each OH with a mineral acid to give a compound I in which R and R<SP>2</SP> together represent an -O- atom; and (6) hydrolysing a compound I in which R<SP>2</SP> is OCOCH 3 to give a compound I in which R<SP>2</SP> is OH.
[GB1436409A]
Patent IE-851907-L (IE)
Title: Endoprosthetic bone joint component.
IPC: A61F2/00
Filed: 1985-07-31
Abstract: A prosthetic component (20; 30) for replacing a region of a bone including an articular surface (12) of a joint has a first surface shaped to approximate the articular surface, and a second surface (23; 33) shaped to extend substantially perpendicularly to the principal trabecular structure (10, 11) in a section through the bone when the first surface replaces the articular surface. In the case of a long bone the second surface is preferably shaped to approximate the fused epiphyseal plate scar (15) of the bone region in question. Also the component preferably has varying elastic modulus, at least in the portion thereof bordering the second surface, to simulate that of the bone replaced thereby.
[US4662888A]
Patent IE-45777-L (IE)
Title: Device for joining floor coverings
IPC: D06N7/00
Filed: 1977-09-27
Abstract: Profiled junction. [FR2367886A1]
Patent IE-882111-L (IE)
Title: A cognisant system
IPC: G06F15/16
Filed: 1988-07-08
Abstract: A cognizant system for managing and controlling a multitude of complex tasks using parallel processing. The cognizant system comprises a plurality of discrete intelligent processors (A) each capable of performing specific tasks and memory means (C) adapted for receiving and presenting information for scrutiny by one of the intelligent processors to determine storage of said information. The memory means (C) has a series of memory elements arranged into prescribed locations to store said information. The cognizant system further comprises means for associating one intelligent processor with another by permitting direct communications therebetween and interface means (D) to input and output information to or from the system. The intelligent processors (A) include a management means (B) dedicated to organising and directing said information to said memory means received from said interface means to said memory means having regard to a cognizance of the system, and to organising and directing communications between said processors and said interface means. [EP0371979A1]
Patent IE-892142-L (IE)
Title: New benzocycloheptene derivatives, process for the¹preparation thereof and pharmaceutical compositions¹containing them
IPC: C07C233/14
Filed: 1989-07-03
Abstract: New benzocycloheptene derivatives of general formula: 
<IMAGE>
 in which: - X is hydrogen, C1-C5 alkyl, cyano or hydroxyl, and - X' is: hydroxyl, a radical OR (R being acyl or optionally substituted C1-C5 alkyl), a radical 
<IMAGE>
 [n being zero, one or two, each of R1 and R2, which are identical or different, being: hydrogen, optionally substituted C1-C5 alkyl, C2-C5 alkenyl or alkynyl, or acyl; or R1 and R2 together with the nitrogen atom to which they are bonded denote either: 
<IMAGE>
 Ra being hydrogen or C1-C5 alkyl and Rb: hydrogen, C1-C5 alkyl, phenyl or phenylalkyl, . or a penta- or hexagonal heterocyclic radical optionally including another heteroatom]; or -X and X' together denote =N-R3 [R3 being optionally substituted C1-C5 alkyl] in racemic form and the corresponding enantiomers. 
<??>These new derivatives and their physiologically acceptable salts can be employed in therapeutics, especially in the treatment of metabolic disorders such as diabetes, obesities and their complications.
Patent IE-842405-L (IE)
Title: Beverage dispenser
IPC: B67D1/08
Filed: 1984-09-20
Abstract: A unit for dispensing beverage has one or more pressure vessels 4 each having an outlet 11 for communication to a dispensing tap 15. Each vessel 4 accommodates a flexible bag 18 containing the beverage having gas in solution. The vessels 4 are pressurised through connection 16 by an air compressor in the unit or from an existing fluid line and this pressurisation serves to ensure dissolution of the gases in the beverage and also to expel the beverage from the bags 18. The beverage is normally sealed in the bags prior to loading into the pressure vessels and the pressure of dispensing may burst a membrane in the port 19 to permit the flow of beverage from the bag. Alternatively the coupling of the pipe 20 with the port 19 may break the membrane for dispensing. There is a refrigeration system 9 with cooling coils 7. <IMAGE>
[GB2146705A]
Patent IE-872532-L (IE)
Title: A medicated skin preparation
IPC: A61L26/00
Filed: 1987-09-18
Abstract: A medicated skin composition comprises a mixture of a copolymer of methylvinylether and methacrylic acid, isopropyl alcohol, citric acid ester plasticizer and 2,4,4'-trichloro-2'-hydroxydiphenyl ether. This composition is applied to the skin to form an antimicrobial barrier.
[EP0260859A1]
Patent IE-893012-L (IE)
Title: Polyamide-imide solutions and process for obtaining them
IPC: D01F6/78
Filed: 1989-09-20
Abstract: The present invention relates to spinnable and mouldable polyamide-imide solutions as well as the process for their preparation. They contain 4 to 35% of a polyamide-imide having a polydispersity index</=2.1 in a solvent mixture containing 45-100% by weight of DMEU and 0-55% of an aprotic polar solvent. They are obtained by the reaction, in dimethylethyleneurea of pH</=7 as polycondensation solvent, of a diisocyanate, an aromatic acid anhydride, optionally an alkali or alkaline earth dicarboxybenzene sulphonate and optionally another aromatic dicarboxylic acid, the polyamide-imide concentration therefore being from 4 to 35%, then by dilution in a polar solvent at a temperature of between 120 DEG  and 200 DEG  C. The solutions thus obtained are limpid at ambient temperature, capable of being stored and have an improved color.
Patent NO-812556-L (NO)
Inventor: CHOWHAN ZAKA-UD-DIN T
IPC: A61K9/20
Filed: 1981-07-27
Abstract: A novel pharmaceutical composition which comprises an acid salt of a thieno-pyridine derived compound, a pharmaceutically acceptable, nonvolatile organic acid (particularly citric acid) and optionally other suitable pharmaceutical excipients.
Patent NO-832136-L (NO)
Inventor: LESEMANN EGON
IPC: A61B5/02
Filed: 1983-06-13
Abstract: 1. Ventilation filter for the open end of the measuring leg of a vein pressure meter comprising a housing open at both ends and whose one end is joined to the measuring leg via a connecting member, and filter material being provided in its clear cross section, characterized in that the filter material is a bacteria-tight and hydrophobic flat filter disk (20; 24) having a pore size between 0.2 and 1.2 mu m, preferably between 0.2 and 0.45 mu m, and that the connecting member is an external cone (13; 26) designed for a detachable plug connection.
Patent NO-841696-L (NO)
Inventor: HOLTMAN DENNIS C
IPC: A61F13/00
Filed: 1984-04-27
Abstract: An absorbent structure is provided which contains a loosely compacted cellulosic fibrous batt having two reservoirs and a connecting channel. The absorbent structure may be an infant diaper, an adult diaper, a sanitary napkin and incontinence pad or the like.
Patent NO-851217-L (NO)
Inventor: KAVKA FRANK
IPC: A61K31/485
Filed: 1985-03-26
Abstract: N-ethoxycarbonyl-14-hydroxynorcodeinone is prepared by contacting N-ethoxycarbonyl-norcodeinone dienol acetate with an aromatic or aliphatic mono-basic or poly-basic peroxy- acid under Reaction Conditions effective for substituting an -OH group in the 14-position of the norcodeinone dienol acetate.In a preferred embodiment the Reaction Conditions include effecting the contacting in the presence of (A) a moderately strong acid having a pK<sub>a</sub> of from about 0.3 to about 3.5, (B) an inert organic solvent, and (C) in the substantial absence of water.Codeine is converted to noroxymorphone by an improved process employing the above method for introducing the 14-hydroxy group into the codeine derivative.
Patent NO-851235-L (NO)
Inventor: KOTHS KIRSTON
IPC: A61P35/00
Filed: 1985-03-27
Abstract: A process for recovering microbially produced IL-2 in a highly pure form from the cellular material of the microorganism that produced it comprising: disrupting the cell membranes of the microorganisms; extracting the disruptate with a chaotropic agent, such as urea, that selectively extracts microbial proteins from the cellular material; solubilizing the IL-2 in the solid phase of the extraction mixture with an aqueous solution of a solubilizing agent, such as SDS, containing a reducing agent; and separating the IL-2 from the resulting solution by an optional extraction with 2-butanol or 2-methyl-2-butanol followed by gel filtration chromatography, oxidizing the IL-2 and purifying the oxidized IL-2 by RP-HPLC.
Patent NO-853005-L (NO)
Inventor: WIMMER GERHARD
IPC: H04B10/114
Filed: 1985-07-29
Abstract: 1. A method of transmitting and receiving for relays (3, 6) arranged in the space between a transmitting system (1) and a receiving system (2), with a respective sensor (4, 7) and a transmitter (5, 8), which are activated separately in terms of time, wherein a transmitting time span (11, 13, 14) follows a receiving time span (10, 12) and wherein the operation is carried out with two or more relays, characterised in that after transmitting time spans (11, 13, 14), in which the same signal (9) is transmitted from the transmitter system (1), the relays (3, 6) are disconnected in each case for a fixed rest interval (15), which is measured so that all relays (3, 6) are simultaneously disconnected for one period (16).